CARL · Carlsmed, Inc.
$12.78
+0.47 (+3.82%)
At close · Jul 29
Market Cap
$334.65M
Shares
27.18M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$50.51M
+85.9%
FY2025
Net Income
-$29.63M
-22.2%
FY2025
Gross Margin
75.31%
+1.5pp
FY2025
Operating Margin
-60.53%
+28.3pp
FY2025
Diluted EPS
-$2.12
+65.3%
FY2025
Operating Cash Flow
-$28.98M
-13.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 |
|---|---|---|---|---|
| $72M – $77M | $56.44M | $50.51M | $27.17M | |
| — | $13.61M | $12.47M | $7.12M | |
| — | $42.83M | $38.04M | $20.05M | |
| — | — | 75.31% | 73.8% | |
| — | $19.05M | $17.02M | $14.3M | |
| — | $38.59M | $35.03M | $21.47M | |
| — | $19.33M | $16.57M | $8.39M | |
| — | — | $281K | $145K | |
| — | $76.96M | $68.61M | $44.17M | |
| — | -$34.13M | -$30.57M | -$24.12M | |
| — | — | -60.53% | -88.8% | |
| — | — | -$30.29M | -$23.98M | |
| — | $1.38M | $1.43M | $1.32M | |
| — | $3.21M | $2.7M | $1.33M | |
| — | $1.53M | $940K | -$135K | |
| — | $0 | $0 | $0 | |
| — | -$32.6M | -$29.63M | -$24.26M | |
| — | — | -58.67% | -89.3% | |
| — | -$32.6M | -$30.22M | -$24.85M | |
| — | -$32.6M | -$29.63M | -$24.26M | |
| USD/shares | — | — | -$2.12 | -$6.11 |
| USD/shares | — | — | -$2.12 | -$6.11 |
| shares | — | — | 14.22M | 4.07M |
| shares | — | — | 14.22M | 4.07M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.51×
EV/EBIT
—
Peer median 25.18×
P/E (TTM)
—
Peer median 35.11×
Peer medians compare against the 28 similar-size Health Information Services companies (of 54 listed).
Key facts
CIK
1794546
CUSIP
14280C105
13F (30d)
11 filings
11 filers
Visit website
Investor relations